IP Library Granted Patent US 8,496,006
Granted Patent B2
US 8,496,006 · App. 12/820,547 · Granted Jul 30, 2013

Methods and devices for passive residual lung volume reduction and functional lung volume expansion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,496,006
App. No.
12/820,547
Granted
Jul 30, 2013
Kind
B2
Abstract

The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.

Claims (8)

1. A method for reducing the residual volume of a hyperinflated lung compartment, said method comprising:

sealing a distal end of a catheter in an airway feeding the lung compartment by using an occluding member that is adapted to be expanded in an airway which feeds the hyperinflated lung compartment such that access to the compartment is provided only through a passage of the catheter when the occluding member is expanded;

allowing air to be expelled from the lung compartment through the passage in the catheter while the patient is exhaling;

blocking air from entering the lung compartment through the catheter passage while the patient is inhaling by using a one-way flow element adapted to be disposed within or in-line with the passage of the catheter so that flow in a distal-to-proximal direction is allowed and flow in a proximal-to-distal direction is inhibited or prevented; and

determining whether collateral ventilation is present in the lung compartment, wherein determining whether collateral ventilation is present comprises detecting, using a flow-measuring device, air flow or accumulation from the isolated lung compartment over time; calculating, using a computer, a value of collateral resistance; and diagnosing collateral ventilation between the target lung compartment and at least one adjacent lung compartment based on the value of collateral resistance calculated by the computer.

2. A method as in claim 1 , further comprising blocking collateral flow channels if it is determined that the hyperinflated lung compartment has collateral flow channels with one or more adjacent lung compartments.

3. A method as in claim 1 , further comprising introducing an oxygen-rich gas into the lung compartment after the volume is reduced to induce or promote absorption atelectasis.

4. A method as in claim 1 , further comprising advancing the catheter through a bronchoscope to position the catheter distal end in the airway before sealing.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →